Update on Mechanisms of Ischemic Acute Kidney Injury
The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Acute renal failure (ARF), classically defined as an abrupt decrease in kidney function that leads to accumulation of nitrogenous wastes such as blood urea nitrogen and creatinine, is a common clinical problem with increasing incidence, serious consequences, unsatisfactory therapeutic options, and an enormous financial burden to society (1–5). ARF may be classified as prerenal (functional response of structurally normal kidneys to hypoperfusion), intrinsic renal (involving structural damage to the renal parenchyma), and postrenal (urinary tract obstruction). This review focuses on intrinsic ARF, which has emerged as the most common and serious subtype in hospitalized patients and can be associated pathologically with acute tubular necrosis (ATN). Consequently, it still is common clinical practice to use the terms intrinsic ARF and ATN interchangeably. Despite decades of pioneering basic research and important technical advances in clinical care, the prognosis for patients with intrinsic ARF remains poor, with a mortality rate of 40 to 80% in the intensive care setting. Two major problems have plagued the field and hindered progress. First, well over 20 definitions for ARF have been used in published studies, ranging from dialysis requirement to subtle increases in serum creatinine (6). In an attempt to standardize the definition and reflect the entire spectrum of the condition, the term acute kidney injury (AKI) has been proposed (4). AKI refers to a complex disorder that comprises multiple causative factors and occurs in a variety of settings with varied clinical manifestations that range from a minimal but sustained elevation in serum creatinine to anuric renal failure. Prerenal azotemia and other fully reversible causes of acute renal insufficiency are specifically excluded from the spectrum of AKI. An inherent shortcoming of this term is the continued reliance on serum creatinine measurements, and the definition of AKI undoubtedly will undergo enhancements as novel early biomarkers for the identification of ARF before the rise in serum creatinine come to light (7). This review avoids the term ATN and uses the expressions AKI and intrinsic ARF transposably. The second problem is an incomplete understanding of the cellular and molecular mechanisms that underlie AKI. This review updates the reader on current advances in basic and translational research that hold promise in human ischemic AKI. Classic concepts are mentioned briefly as founding principles but expanded on only if contemporary findings substantiate or refute them. The reader is referred to recent publications that address the mechanisms that underlie other causes of intrinsic AKI, such as sepsis (8) and nephrotoxins (9). However, from the clinical viewpoint, it is acknowledged that AKI is frequently multifactorial, with concomitant ischemic, nephrotoxic, and septic components and with overlapping pathogenetic mechanisms. Alterations in Morphology If function depends on form, then it follows that mechanisms that are invoked to elucidate kidney dysfunction in AKI also must explain the morphologic alterations. In this regard, the term ATN is a misnomer, because frank tubule cell necrosis is rarely encountered in human ARF. This fact has once again been driven home by careful examination of protocol kidney biopsies that are obtained soon after deceased-donor transplantation (10), which represents a predictable model for ischemic AKI (11). Prominent morphologic features of ischemic AKI in humans include effacement and loss of proximal tubule brush border, patchy loss of tubule cells, focal areas of proximal tubular dilation and distal tubular casts, and areas of cellular regeneration (12). Necrosis is inconspicuous and restricted to the highly susceptible outer medullary regions. The glomeruli are usually unimpressive, unless a primary glomerular disease had caused the ARF. This apparent disparity between the severe impairment of renal function and the relatively subtle histologic changes in AKI traditionally has been bothersome. More recently, however, reconciliation has been forthcoming from a consistent finding of apoptotic cell death in both distal and proximal tubules in both ischemic and nephrotoxic forms of human AKI (9,10). In addition, a great deal of attention has been directed toward the peritubular capillaries, which display a striking vascular congestion, endothelial damage, and leukocyte accumulation (13–15). The mechanisms that underlie these newly emphasized morphologic findings and their implications for the ensuing profound renal dysfunction are detailed herein. Alterations in Hemodynamics An intense and persistent renal vasoconstriction that reduces overall kidney blood flow to approximately 50% of normal has long been considered a hallmark of intrinsic ARF, prompting the previous designation of “vasomotor nephropathy” (1). As if to add insult to injury, the postischemic kidney also displays peculiar regional alterations in blood
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of this multifaceted protective action, NGAL has emerged as a prime therapeutic target in ischaemic AKI [379].”
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Citations
Cites
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., & Bates, D. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090740 · Cited by 3,408
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394 · cited 1×
“protein is markedly upregulated in kidney tubules very early after ischemic AKI in animals (38) and humans (190) and is rapidly excreted in the urine, where it represents a novel, sensitive, early biomarker of ischemic AKI (38,191).”
Self-citationKidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., & Bonventre, J. V. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00433.x · Cited by 1,929 · cited 1×
“cal membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
BackgroundMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationIchimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L., & Sanicola, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4135 · Cited by 1,265 · cited 4×
“KIM-1 protein subsequently was demonstrated to be upregulated in postischemic animal and human kidney tubules, predominantly on the apical membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
MethodInfluentialAcute Renal Failure and Sepsis
Schrier, R. W., & Wang, W. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032401 · Cited by 1,260
Tögel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., & Westenfelder, C. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2005 · Cited by 1,178 · cited 1×
“Fourth, the mode of protection by exogenously administered MSC may be related not to transdifferentiation processes but rather to powerful anti-inflammatory and antiapoptotic mechanisms that are being uncovered (117,124,125).”
BackgroundROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Delayed graft function in kidney transplantation
Perico, N., Cattaneo, D., Sayegh, M. H., & Remuzzi, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17406-0 · Cited by 972 · cited 1×
“This fact has once again been driven home by careful examination of protocol kidney biopsies that are obtained soon after deceased-donor transplantation (10), which represents a predictable model for ischemic AKI (11).”
Background
Cited by
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Hot weather and heat extremes: health risks
Ebi, K. L., Capon, A., Berry, P., Broderick, C., de Dear, R., Havenith, G., Honda, Y., Kovats, R. S., Ma, W., Malik, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01208-3 · Cited by 2,172
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kashani, K., Al-Khafaji, A., Ardiles, T., Artigas, A., Bagshaw, S. M., Bell, M., Bihorac, A., Birkhahn, R., Cely, C. M., Chawla, L. S., et al. (2013) · Critical Care · doi:10.1186/cc12503 · Cited by 1,362
“It is notable therefore that IGFBP7 and TIMP-2 are both involved with the phenomenon of G1 cell cycle arrest during the very early phases of cell injury (Figure 5) [21-24].”
Background
Metadata
- Authors
- Devarajan, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Devarajan, Prasad
- ORCID
- Devarajan, Prasad
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-06
- Volume
- 17
- Issue
- 6
- Pages
- 1503-1520
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2164965999
- Cited by
- 1,026
- References
- 209
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 45 · 2023: 38 · 2022: 39 · 2021: 43 · 2020: 56 · 2019: 53 · 2018: 56 · 2017: 55 · 2016: 82 · 2015: 87 · 2014: 74 · 2013: 64 · 2012: 62
- FWCI
- 26.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P50 DK 52612, R21DK070163, R01-DK53289, P50DK052612, R01DK053289)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Keywords
- acute kidney injury, ischemic acute kidney injury, acute tubular necrosis, renal tubular epithelial cells, tubular epithelial cell proliferation, renal tubular regeneration, renal hypoxia, renal ischemia-reperfusion injury, AKI pathogenesis, kidney injury biomarkers, AKI definitions, serum creatinine limitations
- MeSH terms
- Acute Disease, Adenosine Triphosphate, Animals, Calcium, Humans, Ischemia, Kidney, Kidney Tubules, Models, Biological, Regional Blood Flow, Reactive Oxygen Species, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update on Mechanisms of Ischemic Acute Kidney Injury. https://app.cochat.ai/papers/10.1681/asn.2006010017
- The paper
- Devarajan, P. (2006). Update on Mechanisms of Ischemic Acute Kidney Injury. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2006010017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.